A novel PSEN1 mutation (K239N) associated with Alzheimer's disease with wide range age of onset and slow progression.
OBJECTIVE
To describe a novel mutation (K239N) in the PSEN1 associated with familial Alzheimer's disease (AD).


RESULTS
The proband was a man who developed cognitive decline with marked behavioural abnormalities at age 57. At age 70, he was admitted into a psychiatric facility because of aggressiveness and a suicide attempt. Family history was consistent with autosomal dominant AD. One of the two other family members studied presented also with prominent behavioural symptoms at age 42 and has also been forced into a psychiatric facility because of aggressiveness at age 56. The remainder patient has presented a prototypical AD, but starting at age 71. Direct sequencing of PSEN1 in the three living affected members disclosed a heterozygous G to C transition in exon 7 of PSEN1 leading to the K239N mutation.


CONCLUSIONS
The K239N mutation is associated with autosomal dominant AD with a wide range of age of onset and incomplete penetrance at the age of 65, prominent behavioural features and slow progression.
Alzheimer's Disease and other Cognitive Disorders Unit, Institut d'Investigació Biomédica August Pi I Sunyer (IDIBAPS), Hospital Clínic, Barcelona, Spain. allado@clinic.ub.es
A
A
Lladó
J
J
Fortea
T
T
Ojea
B
B
Bosch
P
P
Sanz
J
J
Valls-Solé
J
J
Clarimon
J L
JL
Molinuevo
R
R
Sánchez-Valle
D017668:Age of Onset; D000368:Aged; D000544:Alzheimer Disease / Q000453:epidemiology / Q000235:genetics* / Q000473:pathology; D018450:Disease Progression; D005260:Female; D020022:Genetic Predisposition to Disease / Q000235:genetics*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009154:Mutation / Q000235:genetics*; D010375:Pedigree; D053764:Presenilin-1 / Q000235:genetics*
C508853:PSEN1 protein, human; D053764:Presenilin-1